Citations

Showing 10 of 107969 citations.

Personalized Therapy Selection by Integration of Molecular Cancer Classification by the 92-Gene Assay and Tumor Profiling in Patients With Cancer of Unknown Primary
Kasi, Pashtoon Murtaza , Ma, Li , Hart, Lowell L., Wong, Jenna , Spigel, David R. , Schnabel, Catherine A. , Reeves, James A. , Hálfdánarson, Þorvarður R. , Treuner, Kai , Greco, Frank A. , Fuentes, Harry E , Kasi, Pashtoon Murtaza , Spigel, David R , Halfdanarson, Thorvardur R , Treuner, Kai , Greco, F Anthony , Fuentes, Harry E , Wong, Jenna

Mayo Clinic

JCO Precision Oncology | September 4, 2024 | Volume: No volume available | Issue: 8 | Pages: No page available

10.1200/po.24.00191 | PMID 39231374 Get It

PURPOSE Cancer of unknown primary (CUP) is a syndrome comprising metastatic cancers without a clinically identified primary site. Although patients with CUP have an unfavorable prognosis, treatment with site-specific therapies guided by clinical features, standard pathology, and molecular assays can improve overall survival. The 92-gene assay (CancerTYPE ID) is a gene expression–based classifier that helps identify the tissue of origin for metastatic cancers with unknown or uncertain diagnoses. This study reports the frequency of selected molecular aberrations of oncogenes, including KRAS, IDH1/2, BRCA1/2, and BRAF, in patients with CUP in the MOSAIC database to highlight potential treatment options. METHODS MOSAIC is a database of patients with CUP submitted for CancerTYPE ID testing and NeoTYPE biomarker testing. Tumor biopsy samples were analyzed by CancerTYPE ID for tumor type identification and further tested for molecular aberrations of oncogenes, including KRAS, IDH1/2, BRCA1/2, and BRAF. RESULTS CancerTYPE ID identified a specific tumor type in 92.5% (2,929 of 3,168) of CUP cases in the MOSAIC database. The most commonly identified histological type was adenocarcinoma (75.4%), with pancreaticobiliary being the most common molecularly diagnosed cancer (24.9%). Aberrations in KRAS, IDH1/2, BRCA, and BRAF genes were identified in 18.8% (n = 597) of biopsies. A cancer-specific US Food and Drug Administration (FDA)–approved or investigational targeted therapy was potentially available for 24.6% (n = 147) of these patients. CONCLUSION This retrospective analysis supports incorporating CancerTYPE ID into the evaluation for patients with CUP to help determine the tissue of origin and identify actionable genetic alterations. This approach may allow more patients with CUP to benefit from site-specific FDA-approved targeted therapies or enrollment into clinical trials.
Mitigating the Risk of Instability After Reverse Shoulder Arthroplasty
Bindi, Victoria E. , Buchanan, Timothy R. , Cueto, Robert J. , Hones, Keegan M. , Wright, Thomas W. , King, Joseph J. , Hao, Kévin A. , Schoch, Bradley S , King, Joseph J , Hao, Kevin A , Hones, Keegan M , Schoch, Bradley S.

Mayo Clinic

JBJS Reviews | September 4, 2024 | Volume: 12 | Issue: 9 | Pages: No page available

10.2106/jbjs.rvw.24.00095 | PMID 39226391 Get It

» Instability and dislocation after reverse shoulder arthroplasty may occur in up to 31% of patients. » Clinical risk factors for instability include younger age, male sex, increased body mass index, preoperative diagnosis of proximal humerus fracture or rotator cuff pathology, history of instability of the native shoulder or after surgery, and a medical history of Parkinson’s disease. » Patients with rheumatoid arthritis and decreased proximity to the coracoid may also be at greater risk. » In patients at a high risk of instability, surgeons should consider a more lateralized prosthesis (particularly in patients with an incompetent rotator cuff), repairing the subscapularis (particularly when using a medialized prosthesis), and upsizing the glenosphere (>40 mm in male and 38–40 mm in female patients). » While potentially useful, less evidence exists for the use of a constrained liner (particularly with a lateralized glenosphere and/or in low-demand patients) and rotating the polyethylene liner posteriorly to avoid impingement. Level of Evidence: Level V . Narrative Review. See Instructions for Authors for a complete description of levels of evidence.
Risk Factors for Inadequate Bowel Preparation in Colonoscopy: A Comprehensive Systematic Review and Meta-Analysis
Aboursheid, Tarek , Ali, Adel Hajj , Albunni, Hashem , Mohamed, Mouhand , Vargas, Alejandra , Hadaki, Nwal , Alsakarneh, Saqr , Rex, Douglas K., Guardiola, John , Aboursheid, Tarek , Mohamed, Mouhand F H , Vargas, Alejandra , Guardiola, John J , Albunni, Hashem N , Alsakarneh, Saqr G , Beran, Azizullah

Mayo Clinic

American Journal of Gastroenterology | September 4, 2024 | Volume: 119 | Issue: 12 | Pages: 2389-2397

10.14309/ajg.0000000000003073 | PMID 39225554 Get It

INTRODUCTION: Inadequate bowel preparation (IBP) before colonoscopy remains a common problem. This meta-analysis aimed to assess the risk factors associated with IBP. METHODS: We searched multiple databases for studies that assessed risk factors for IBP after adjustment and reported the data as adjusted odds ratios with 95% confidence intervals. Meta-analyses were conducted using a random-effects model, and pooled adjusted odds ratios for risk factors reported in ≥ 3 studies were constructed. RESULTS: One hundred fifty-four studies with 358,257 participants were included. We analyzed 48 unique risk factors. Sociodemographic predictors of IBP were Medicaid insurance, obesity, current tobacco use, age ≥ 65 years, Black race, low education level, male sex, and unmarried status. Comorbidity-related predictors of IBP were any psychiatric disease, cirrhosis, American Society of Anesthesiologists (ASA) class ≥ 3, poor functional status, constipation, diabetes, previous abdominopelvic surgery, and hematochezia. Medication-related predictors of IBP were tricyclic antidepressants, antidepressants, opioids, nontricyclic antidepressants, and calcium channel blockers. Preparation/procedure-related predictors of IBP were brown liquid rectal effluent, any incomplete bowel preparation (BP) intake, lack of split-dose BP, increased BP-to-defecation interval, any nonadherence to dietary instructions, increased BP-to-colonoscopy interval, any BP intolerance, previous IBP, and inpatient status. Although afternoon colonoscopy was a predictor of IBP, subgroup analysis of prospective studies revealed no significant association. DISCUSSION: Our meta-analysis focused on adjusted risk factors to provide precise estimates of the most important risk factors for IBP. Our findings could help develop a validated prediction model to identify high-risk patients for IBP, improve colonoscopy outcomes, reduce the need for repeat colonoscopies, and reduce associated healthcare costs.
Integrating Human Factors to Enhance Healthcare Distance Simulation
Bailey, Shannon K. T. , Hughes, Ashley M. , Dong, Yue , Robertson, Jamie M. , Ray, Jessica M.

Mayo Clinic

Proceedings of the International Symposium on Human Factors and Ergonomics in Health Care | September 4, 2024 | Volume: 13 | Issue: 1 | Pages: 94-97

10.1177/2327857924131055 Get It

The Human Factors (HF) track at the Annual Healthcare Distance Simulation Summit focuses on improving the effectiveness of distance simulation utilizing human factors principles. During this presentation, we will 1. review the work to-date of the HF track of the Distance Simulation Summit, 2. discuss current opportunities for collaboration between human factors practitioners and simulationists, and 3. introduce ideas for future work. The potential target audiences for this discussion are researchers and practitioners who are interested in or involved in distance simulation or simulation in healthcare generally, educators who want to learn how to use distance simulation effectively and efficiently, and healthcare professionals and students who want to enhance their skills and knowledge about distance simulation. The presentation will stimulate discussion and feedback from the audience, which can enrich the knowledge base and generate new research questions and directions for distance simulation.
Long-term Outcomes of Partial Meniscectomy for Degenerative Medial Meniscus Posterior Root Tears
Lamba, Abhinav , Regan, Christina , Levy, Bruce A. , Stuart, Michael J. , Krych, Aaron J. , Hevesi, Mario , Krych, Aaron J , Stuart, Michael J , Lamba, Abhinav , Hevesi, Mario

Mayo Clinic

Orthopaedic Journal of Sports Medicine | September 4, 2024 | Volume: 12 | Issue: 9 | Pages: No page available

10.1177/23259671241266593 | PMID 39247528 Get It

Background: Previous studies have demonstrated that medial meniscus posterior root tear (MMPRT) repair is superior to debridement in terms of patient-reported outcomes, rates of conversion to total knee arthroplasty (TKA), and long-term costs. Despite the known poor midterm outcomes, there is a paucity of long-term results of partial meniscectomy for degenerative MMPRTs. Purpose: To 1) evaluate long-term patient-reported and radiographic outcomes of patients who underwent partial medial meniscectomy (PMM) for MMPRTs, and 2) determine the rate of and risk factors for conversion to total knee TKA. Study Design: Case series; Level of evidence, 4. Methods: A previously identified cohort of 26 patients treated with partial meniscectomy for isolated MMPRTs between 2005 and 2013 was prospectively followed for long-term outcomes at a minimum 10-year follow-up. Patients were evaluated for International Knee Documentation Committee (IKDC) outcome score, reoperation, and conversion to TKA. Failure was defined as conversion to arthroplasty or a severely abnormal IKDC subjective score <75.4. Results: This study included 26 patients (10 men, 16 women; mean age, 54 ± 8.7 years [range, 38-71 years] at diagnosis; body mass index, 32.9 ± 5.5) who were followed for a mean of 14.0 ± 3.6 years (range, 10.1-19.6 years). At the final follow-up, 1 patient was deceased and 18 (72%) of the remaining 25 patients had progressed to TKA, with 1 (4%) patient undergoing repeat meniscectomy. The 6 (24%) patients who had not progressed to TKA or revision surgery reported a mean IKDC score of 57 ± 23. Nineteen patients underwent subsequent surgery and 5 demonstrated severely abnormal IKDC scores resulting in a clinical failure rate of 96% (24 of the 25 living patients) at a mean 14-year follow-up. Conclusion: PMM for medial meniscus posterior horn root tears demonstrated 72% progression to TKA and 96% failure according to subjective clinical outcomes at a minimum 10-year follow-up.
Localized tacrolimus therapy: innovations in peripheral nerve regeneration through advanced drug delivery systems
Millesi, Elena , Millesi, Flavia , Rechberger, Julian S. , Daniels, David J. , Radtke, Christine , Mardini, Samir

Mayo Clinic

Therapeutic Delivery | September 4, 2024 | Volume: 15 | Issue: 10 | Pages: 743-748

10.1080/20415990.2024.2392481 | PMID 39229814 Get It

Anaphylactic Shock Caused by Eating Buckwheat
Orga-Dumitriu, Dan, Porr, Corina , Porr, Corina , Harris, Dana M.

Mayo Clinic

Journal of Clinical Medicine | September 4, 2024 | Volume: 13 | Issue: 17 | Pages: 5243

10.3390/jcm13175243 | PMID 39274456 Get It

Background: Urticaria is a common disease with a marked influence on quality of life. The key cell involved is the mast cell, which can be activated by a vast variety of stimuli, and the major mediator is histamine. Allergic urticaria is a disorder with a large variety of causes: food, drugs, insect venom, skin contact with allergens, and physical exercise. Buckwheat consumption has increased in European countries and the USA because it is gluten-free. It can trigger anaphylactic shock if ingested, inhaled, or handled with the hands. Five common buckwheat allergens named Fag e1 to 5 (Fag e1, 2, and 3 are considered the major allergens) and two tartary buckwheat allergens named Fag t1 and Fag t2 have been described. Method: We present the case of a patient who experienced two anaphylactic shocks and in whom the etiological factor was buckwheat. The patient presented to the Allergology department for the evaluation of two episodes of severe allergic reactions that required emergency therapy, episodes that involved the loss of consciousness and were of major severity. At each anaphylactic shock, an ambulance was requested, and emergency therapy was administered, leading to the patient’s recovery within a few hours. Diagnosis: Since each episode occurred a few minutes after eating, the diagnosis was established based on a detailed anamnesis and prick skin tests, followed by specific IgE dosages. Other foods consumed by the patient, assessed by prick skin testing and specific IgE dosages of suspected foods, were excluded as the etiological cause. Increased levels of buckwheat-specific immunoglobulin E were highlighted, thus identifying the etiological agent. The treatment of anaphylactic shock was performed urgently by the ambulance crew with adrenaline, infusion solutions, cortisone preparations, and antihistamines. Result: Following the treatment that was initiated, there was a partial remission of the lesions after a few hours. Conclusions: Buckwheat allergy is rare, but it produces symptoms that affect the skin, gastrointestinal tract, and respiratory tract, as well as anaphylaxis. In a professional environment, it can trigger allergic rhinitis, asthma, and hives. Although buckwheat allergens have been described, their clinical relevance has only been studied in a small number cases. In current practice, the only commercially available allergen is Beech e2 per the ImmunoCAP ISAC microarray. Diagnosis can be difficult in clinical practice. This reported case suggests the need for a thorough anamnesis, since buckwheat is consumed as a hidden allergen, and in Europe, it is not necessary to label foods containing this allergen.
Comment on: Cost‐effectiveness of treating childhood acute myeloid leukemia at a tertiary care center in North India
Singh, Manraj , Bakhshi, Sameer , Ganguly, Shuvadeep , Sra, Manraj Singh

Mayo Clinic

Pediatric Blood & Cancer | September 4, 2024 | Volume: 72 | Issue: 1 | Pages: No page available

10.1002/pbc.31305 | PMID 39228042 Get It

Children and Adolescents With Sickle Cell Disease and Skull Infarction: A Systematic Review
Vivar, Alexia Peréz , García-Guáqueta, Danna P. , Setty, Bindu N. , Neri, Caitlin M. , Torres, Alcy , Perez, Alexia M , Torres, Alcy R

Mayo Clinic

Journal of Child Neurology | September 4, 2024 | Volume: 39 | Issue: 11-12 | Pages: 433-439

10.1177/08830738241274352 | PMID 39228213 Get It

Introduction Skull infarction is an uncommonly reported complication of sickle cell disease. We aimed to characterize the clinical and imaging features of skull infarction in pediatric patients with sickle cell disease. Methods We searched the PubMed database for case reports on skull bone infarction in pediatric patients with sickle cell disease. Out of 67 records retrieved, 15 met inclusion criteria, and a 16th case reported by the senior author was included. We extracted and analyzed clinical and imaging data. Results The most common symptom at onset was headache (88%). Bilateral skull infarction (50%) and parietal bone involvement (82%) were frequent imaging findings. Epidural hematoma developed in 65% of the cases, 30% of patients required drainage, and exchange infusion was reported in 18%. No fatal outcomes were reported. Conclusions Skull infarction is a potentially severe complication of sickle cell disease presenting unique clinical challenges. Acute headaches should raise suspicion for this condition and may require additional investigation.
Evaluation of Interprofessional Delivery of Diabetes Medication Management Training Among Family Medicine Residents
Davis, K.A. , Moore, Elise , Samuelson, Britanee, Stonerock, Lauren R. , Miller, Nathaniel E. , Davis, Amanda, Davis, Katherine , Stonerock, Lauren, Miller, Nathaniel E , Davis, Amanda

Mayo Clinic

Journal of Primary Care & Community Health | September 4, 2024 | Volume: 15 | Issue: No issue available | Pages: No page available

10.1177/21501319241276801 | PMID 39228176 Get It

Objective: Diabetes-related care makes up approximately 24% of outpatient clinic visits. Therefore, confidence and understanding of diabetes management is necessary for family medicine residents. Methods: We developed a combined lecture and simulation lab curriculum utilizing a registered nurse and pharmacist to deliver education to 20 family medicine learners. Pre and post surveys of the educational material were completed in 2 sections including one gauging medical knowledge and a second part gauging level of comfort. Results: Of the learners who participated, fourteen completed the pre-post surveys. Most (53%) respondents improved their scores, while 20% scored the same 27% scored worse. The overall average score increased 57% to 70% and improvement was statistically significant ( P < .05). All learners improved confidence by at least 1 point. Conclusion: An interprofessional team utilizing a lecture curriculum focusing on providing education on effective prescribing, medication safety profiles, and resource availability, showed improvement in confidence but mixed knowledge benefit. Further modifications to the curriculum may yield further educational gains.